Commentary on "Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data".

Colevas, A Dimitrios

Commentary on "Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data". [electronic resource] - The oncologist 09 2017 - 1022-1023 p. digital

Publication Type: Journal Article; Comment

1549-490X

10.1634/theoncologist.2017-0232 doi


Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Chemoradiotherapy
Cisplatin
Head and Neck Neoplasms
Humans